Korsana Biosciences, Inc. (KRSA)

30.14 -0.08 (-0.26%) USD  |  NASDAQ  |  Oct 30, 16:00
30.13 -0.01 (-0.03%) After-Hours: 20:00
More

Korsana Biosciences Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for KRSA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2025. Start Trial.
Date Value
October 05, 2026 --
September 28, 2026 --
September 14, 2026 --
Date Value
February 23, 2026 --
February 02, 2026 --
December 31, 2025 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
Q32 Bio, Inc. Upgrade
IRulya Therapeutics, Inc. Upgrade
Climb Bio, Inc. Upgrade
PepGen Inc. Upgrade
Bridgebio Oncology Therapeutics, Inc. Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade